Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

Market Strengths and Weaknesses in Biosimilars

August 1, 2012

Pharmaceutical Technology

An examination of the current and projected market for biosimilars, development costs for biosimilars compared with small-molecule generic drug, and partnerships in biosimilars.

High-Potency Manufacturing Remains Strong

July 2, 2012

Pharmaceutical Technology

Companies roll out expansions in manufacturing high-potency APIs and finished products.

35th Anniversary Special: New Models in Contract Services

July 2, 2012

Pharmaceutical Technology

Sponsor companies' increasing focus on strategic outsourcing has changed the rules of the game.

Q&A with Thomas E. D'Ambra, AMRI

July 2, 2012
Pharmaceutical Technology

A Q&A with Thomas E. D'Ambra, Chairman, CEO, & President of AMRI, on recent industry trends.

Reflecting on 35 Years of Procurement Transformation

July 2, 2012

Pharmaceutical Technology

The past three decades have driven a purchasing evolution to a procurement revolution.

A Look into the Future of Pharmaceutical Outsourcing: Perspectives from Jim Miller, president of PharmSource

July 2, 2012

Pharmaceutical Technology

Jim Miller, president of PharmSource, examines the future direction of CROs/CMOs and the factors influencing the pharmaceutical contract services sectors.

Future Innovation

July 2, 2012
Pharmaceutical Technology

Presidents of leading associations offer views on the industry's future.

Pharmaceutical Technology: 35 Years and Going Strong

July 2, 2012

Pharmaceutical Technology

Taking time to appreciate the industry's greatest achievements will inspire growth ahead.

Biomanufacturing Innovation

June 2, 2012

Pharmaceutical Technology

Industry wants more innovation, but can suppliers meet customer needs?

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here